Claire Thomas
Director/Board Member at REBUS HOLDINGS, INC.
Net worth: - $ as of 30/12/2023
Claire Thomas active positions
| Companies | Position | Start | End |
|---|---|---|---|
| REBUS HOLDINGS, INC. | Director/Board Member | 11/10/2016 | - |
| Independent Dir/Board Member | 11/10/2016 | - | |
Agensys, Inc.
 Agensys, Inc. Miscellaneous Commercial ServicesCommercial Services Agensys, Inc. develops a pipeline of therapeutic fully human monoclonal atibodies (mAbs) to treat cancer. It develops a pipeline of naked and antibody-drug conjugated (ADC) therapeutic antibodies to treat cancer indications, including prostate, kidney, pancreas, ovary, bladder, lung, colon, breast, and skin. The company was founded in 1997 and is headquartered in Santa Monica, CA. | Director/Board Member | - | - |
Career history of Claire Thomas
Former positions of Claire Thomas
| Companies | Position | Start | End |
|---|---|---|---|
| ASTELLAS PHARMA INC. | Corporate Officer/Principal | 30/07/2013 | 29/06/2016 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 31/07/2008 | 31/12/2012 |
Training of Claire Thomas
| University of Illinois | Doctorate Degree |
Statistics
International
| United States | 5 |
| Japan | 2 |
Operational
| Corporate Officer/Principal | 2 |
| Director/Board Member | 2 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| ASTELLAS PHARMA INC. | Health Technology |
| REBUS HOLDINGS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Agensys, Inc.
Agensys, Inc. Miscellaneous Commercial ServicesCommercial Services Agensys, Inc. develops a pipeline of therapeutic fully human monoclonal atibodies (mAbs) to treat cancer. It develops a pipeline of naked and antibody-drug conjugated (ADC) therapeutic antibodies to treat cancer indications, including prostate, kidney, pancreas, ovary, bladder, lung, colon, breast, and skin. The company was founded in 1997 and is headquartered in Santa Monica, CA. | Commercial Services |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Claire Thomas
- Experience